Literature DB >> 4729249

A canine model of granulomatous lung disease: alterations in pulmonary structure and function.

H W Fritts, J Martinez, R S Irwin, H M Thomas, R D Wigle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4729249      PMCID: PMC2441297     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


× No keyword cloud information.
  7 in total

1.  THE INFLUENCE OF HYDROGEN ION CONCENTRATION AND HYPOXIA ON THE PULMONARY CIRCULATION.

Authors:  Y ENSON; C GIUNTINI; M L LEWIS; T Q MORRIS; M I FERRER; R M HARVEY
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  Studies of the ventilation-perfusion relationships in the lungs of subjects with chronic pulmonary emphysema, following a single intravenous injection of radioactive krypton (Kr85). I. Presentation and validation of a theoretical model.

Authors:  H P GURTNER; W A BRISCOE; A COURNAND
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Effect of adjuvant (Freund's type) and its components on the organs of various animal species; a comparative study.

Authors:  A LAUFER; C TAL; A J BEHAR
Journal:  Br J Exp Pathol       Date:  1959-02

4.  Stimulation of the reticuloendothelial system in the rabbit by Freund's adjuvant.

Authors:  J C RUPP; R D MOORE; M D SCHOENBERG
Journal:  Arch Pathol       Date:  1960-07

5.  Evaluation of shunt flow through nonventilated gas-filled and gas-free alveoli in dogs.

Authors:  D F Rochester; H M Thomas
Journal:  J Appl Physiol       Date:  1972-07       Impact factor: 3.531

6.  The lesser circulation in pulmonary fibrosis secondary to sarcoidosis and its relationship to respiratory function.

Authors:  C Emirgil; B J Sobol; W H Herbert; K Trout
Journal:  Chest       Date:  1971-10       Impact factor: 9.410

7.  Observations on a model of prolifer- ative lung disease. I. Transpulmonary arteriovenous differences of lactate, pyruvate, and glucose.

Authors:  B Strauss; P R Caldwell; H W Fritts
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.